Literature DB >> 8792090

Insulin action in man.

A J Scheen1, P J Lefèbvre.   

Abstract

Insulin action is crucial for the regulation of glucose metabolism. Insulin plays a key role in suppressing endogenous glucose production by the liver, both in fasting and postprandial states. Insulin is also necessary for the maintenance of normal rates of glucose oxidation and storage in insulin-sensitive tissues and for the prevention of excessive gluconeogenic substrate production. Various methods have been developed to assess insulin action in vivo, essentially at liver and muscle sites. Such methods evaluate the effect of exogenous or endogenous insulin, using respectively the open-loop approach (interruption of the feedback loop by inhibiting endogenous insulin secretion) or the closed-loop approach (mathematical modelling of the insulin-glucose feedback loop). Knowledge of the successive steps of cellular insulin action has markedly improved during the last ten years. Preceptor, receptor and postreceptor levels need to be considered since they may be affected in insulin-resistant states. This general progress in the understanding of insulin action in man improves our approach to the complex pathophysiology of non-insulin-dependent diabetes mellitus and opens up new prospects for treatment of the insulin-resistant syndrome which is associated with several atherosclerotic risk factors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8792090

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  10 in total

1.  Betatrophin: a hormone that controls pancreatic β cell proliferation.

Authors:  Peng Yi; Ji-Sun Park; Douglas A Melton
Journal:  Cell       Date:  2013-04-25       Impact factor: 41.582

2.  Sex steroids influence glucose oxidation through modulation of insulin receptor expression and IRS-1 serine phosphorylation in target tissues of adult male rat.

Authors:  Thirupathi Muthusamy; Palaniappan Murugesan; Chinnapaiyan Srinivasan; Karundevi Balasubramanian
Journal:  Mol Cell Biochem       Date:  2011-02-08       Impact factor: 3.396

3.  Betatrophin provides a new insight into diabetes treatment and lipid metabolism (Review).

Authors:  Jin-Zhou Zhu; Chao-Hui Yu; You-Ming Li
Journal:  Biomed Rep       Date:  2014-05-20

4.  Dietary soy and tea combinations for prevention of breast and prostate cancers by targeting metabolic syndrome elements in mice.

Authors:  Jin-Rong Zhou; Linglin Li; Weijun Pan
Journal:  Am J Clin Nutr       Date:  2007-09       Impact factor: 7.045

5.  The Tellurium compound, AS101, increases SIRT1 level and activity and prevents type 2 diabetes.

Authors:  Meital Halperin-Sheinfeld; Asaf Gertler; Eitan Okun; Benjamin Sredni; Haim Y Cohen
Journal:  Aging (Albany NY)       Date:  2012-06       Impact factor: 5.682

6.  The Soybean Peptide Vglycin Preserves the Diabetic β-cells through Improvement of Proliferation and Inhibition of Apoptosis.

Authors:  Hua Jiang; Yuxing Tong; Dongjing Yan; Shaohui Jia; Claes-Goran Ostenson; Zhengwang Chen
Journal:  Sci Rep       Date:  2015-10-29       Impact factor: 4.379

7.  Influence of Preexisting Diabetes on Survival After a Breast Cancer Diagnosis in First Nations Women in Ontario, Canada.

Authors:  Amanda J Sheppard; Anna M Chiarelli; Anthony J G Hanley; Loraine D Marrett
Journal:  JCO Glob Oncol       Date:  2020-02

Review 8.  Prognostic impact of body mass index (BMI) in HER2+ breast cancer treated with anti-HER2 therapies: from preclinical rationale to clinical implications.

Authors:  Francesca Ligorio; Luca Zambelli; Giovanni Fucà; Riccardo Lobefaro; Marzia Santamaria; Emma Zattarin; Filippo de Braud; Claudio Vernieri
Journal:  Ther Adv Med Oncol       Date:  2022-03-08       Impact factor: 8.168

9.  Identification of a Prognostic Signature Based on the Expression of Genes Related to the Insulin Pathway in Early Breast Cancer.

Authors:  Alessandra Gennari; Mariapia Sormani; Matteo Puntoni; Veronica Martini; Adriana Amaro; Paolo Bruzzi; Ulrich Pfeffer
Journal:  Breast Care (Basel)       Date:  2020-08-28       Impact factor: 2.268

Review 10.  Potential Bioactive Compounds from Seaweed for Diabetes Management.

Authors:  Yusrizam Sharifuddin; Yao-Xian Chin; Phaik-Eem Lim; Siew-Moi Phang
Journal:  Mar Drugs       Date:  2015-08-21       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.